SCHEMBL935220

SCHEMBL935220

Cc1nc(C(C)C)c[nH]1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2035618 0.83
SCHEMBL467177 0.81
SCHEMBL16383868 0.81
SCHEMBL9210154 0.81
SCHEMBL29501262 0.78
SCHEMBL24688167 0.78
SCHEMBL28415440 0.78
SCHEMBL9616715 0.76
SCHEMBL26075732 0.75
SCHEMBL20998283 0.75

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 177 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119162734-A Preparation method and application of bimetal organic framework composite fiber membrane 天津工业大学 2024-12-20 CN claimed
CN-119145226-A Preparation method and application of bimetal MOF modified nanofiber membrane with antibacterial performance 天津工业大学 2024-12-17 CN claimed
WO-2008119624-A1 CURABLE EPOXY RESIN COMPOSITION ABB RESEARCH LTD (CH) 2008-10-09 WO claimed
EP-4526365-A1 ACRYLATE-EPOXY RESIN COMPOSITIONS Lyondellbasell Composites LLC (US) 2025-03-26 EP disclosed
US-12187702-B2 Sulfonamideurea compounds INFLAZOME LIMITED (IE) 2025-01-07 US disclosed
CN-119162734-A Preparation method and application of bimetal organic framework composite fiber membrane 天津工业大学 2024-12-20 CN disclosed
CN-119145226-A Preparation method and application of bimetal MOF modified nanofiber membrane with antibacterial performance 天津工业大学 2024-12-17 CN disclosed
US-20240239772-A1 PROTEASE INHIBITORS AND METHODS OF USE THE CLEVELAND CLINIC FOUNDATION 2024-07-18 US disclosed
US-20240239772-A1 PROTEASE INHIBITORS AND METHODS OF USE THE CLEVELAND CLINIC FOUNDATION 2024-07-18 US disclosed
US-12036209-B2 Compounds and methods for the targeted degradation of Interleukin-1 receptor-associated kinase 4 polypeptides ARVINAS OPERATIONS, INC. (US) 2024-07-16 US disclosed
US-12036209-B2 Compounds and methods for the targeted degradation of Interleukin-1 receptor-associated kinase 4 polypeptides ARVINAS OPERATIONS, INC. (US) 2024-07-16 US disclosed
US-6147097-A METHOD FOR TREATING AIDS SHIONOGI & CO., LTD. (JP) 2000-11-14 US disclosed
EP-0585014-B1 Process for the preparation of 2-(un)substituted 4-alkylimidazoles SHIONOGI & CO (JP) 2000-02-23 EP disclosed
US-5910506-A IMIDAZOLE DERIVATIVES, E.G.5-(3,5-DICHLOROPHENYLTHIO)-1,2-DIMETHYL-4-ISOPROPYL-1H-IMIDAZOLE; VIRICIDES; AIDS; NONTOXIC SHIONOGI & CO., LTD. (JP) 1999-06-08 US disclosed
EP-0786455-A1 IMIDAZOLE DERIVATIVE SHIONOGI & CO., LTD. (JP) 1997-07-30 EP disclosed
US-5312927-A Preparation of imidazoles SHIONOGI & CO., INC. (JP) 1994-05-17 US disclosed
EP-0585014-A2 Process for the preparation of 2,5-disubstituted imidazoles SHIONOGI & CO., LTD. (JP) 1994-03-02 EP disclosed
EP-0425100-A2 Salicylate of 1-isopropyl-2-methyl imidazole as an epoxy resin curative TEXACO CHEMICAL COMPANY (US) 1991-05-02 EP disclosed
US-5001211-A Salicylate of 1-isopropyl-2-methyl imidazole as an epoxy resin curative TEXACO CHEMICAL COMPANY (US) 1991-03-19 US disclosed
EP-0012566-A1 Electric windings and production thereof Hitachi, Ltd. (JP) 1980-06-25 EP disclosed